Esthesioneuroblastoma staging

Esthesioneuroblastoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Esthesioneuroblastoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Esthesioneuroblastoma staging On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Esthesioneuroblastoma staging All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Esthesioneuroblastoma staging
CDC on Esthesioneuroblastoma staging
Esthesioneuroblastoma staging in the news
Blogs on Esthesioneuroblastoma staging
Directions to Hospitals Treating Esthesioneuroblastoma
Risk calculators and risk factors for Esthesioneuroblastoma staging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Staging

Group	Features
Group A	Tumor is limited to the nasal cavity
Group B	Tumor is limited to the nasal cavity and paranasal sinuses
Group C	Tumor extends beyond the nasal cavity and paranasal sinuses Base of skull Intracranial compartment Orbit Distant metastatic disease
Group D	Cervical nodal metastases